[DOI] [PubMed] [Google Scholar] 27.Scrocchi LA, Brown TJ, MaClusky N, Brubaker PL, Auerbach AB, Joyner AL, et al
Who is at Risk for Deficiency : Anyone who is not a full-time lifeguard in Southern California may be at risk
While AUA does not yet explicitly mention GLP-1 agonists, the emerging evidence (below) suggests these agents could play a role in improving metabolic hypogonadism and should be considered in consultation with endocrinologists for obese men with fertility issues
Lipoprotein-inspired nanoparticles for cancer theranostics
For patients requiring frequent acute treatment, switching to gepants (CGRP receptor antagonists) may be an appropriate alternative, as current evidence suggests these medications do not cause medication adaptation headache
Holliday MW Jr, Frost L, Navaneethan SD